Objective The gene therapy voretigene neparvovec (VN) is the first Food and Drug
Administration–approved treatment for vision loss owing to the ultra-rare RPE65-mediated inherited …

Background Several disease-modifying therapies (DMTs) treat relapsing–remitting multiple
sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS). Few comprehensive …

Poliovirus surveillance plays a critical role in achieving and certifying eradication and will play
a key role in the polio endgame. Environmental surveillance can provide an opportunity to …

Despite increased efforts and spending toward polio eradication, it has yet to be eliminated
worldwide. We aimed to project economic costs of polio eradication compared to permanent …

Background Measles causes significant childhood morbidity in Nigeria. Routine immunization
(RI) coverage is around 40% country-wide, with very high levels of spatial heterogeneity (3…

Background HIV treatment has been available in Mozambique since 2004, but coverage of,
and retention in, antiretroviral therapy (ART) remain suboptimal. Therefore, to increase …

Background Up to 31% of patients with relapsing-remitting multiple sclerosis (RRMS)
discontinue treatment with disease-modifying drug (DMD) within the first year, and of the patients …

Introduction Japanese encephalitis (JE) is a mosquito-borne viral infection of the brain that
can cause permanent brain damage and death. In the Philippines, efforts are underway to …

Objective This study evaluated the potential cost-effectiveness of cervical cancer screening
in HIV treatment clinics in Nairobi, Kenya. Methods A Markov model was used to project …

Objectives To estimate the modified societal costs of cervical cancer treatment in Kenya;
and to compare the modified societal costs of treatment for pre-cancerous cervical lesions …